SymphonyIRI Summit 2011 to focus on ‘competitive edge’
SymphonyIRI Group Inc. has announced the roster of keynote speakers from the consumer packaged goods (CPG), retail and health care industries for its Summit 2011 next week in Miami Beach, Fla.
Supplier News
Qualitest approved for toresmide tablets
Qualitest Pharmaceuticals has received clearance for toresmide tablets, a diuretic medication. The Endo Pharmaceuticals subsidiary said Thursday that the Food and Drug Administration has approved toresmide tablets in 5 mg, 10 mg, 20 mg and 100 mg strengths.
Wrigley offers personalized Extra gum packs
Wm. Wrigley Jr. Co. is enabling chewers of its Extra sugar-free gum to create and buy personalized packs featuring their photos and designs via its first-ever custom-packaging offer, dubbed MyExtra. Under the program unveiled Monday, consumers can visit www.MyExtraGum.
Physicians Formula launches Eye Booster
Physicians Formula has kicked off an online photo contest for the launch of its new Eye Booster lash line.
P&G, Teva to form OTC health care venture
Procter & Gamble Co. and Teva Pharmaceutical Industries Ltd. plan to form a joint venture that will combine their over-the-counter health care businesses in all markets outside North America.
Covidien CEO to retire; successor named
Richard Meelia is slated to retire as president and chief executive officer of Covidien this summer. The pharmaceutical and health care products company said plans call for Meelia to retire on July 1 and then serve as nonexecutive chairman during a transition period of up to one year.
Boehringer-Ingelheim helps raise colon cancer awareness
The fact that colon cancer is preventable but still kills 50,000 people every year has led Boehringer-Ingelheim Consumer Health Care to team up with the Colon Cancer Alliance on a yearlong project to raise awareness and help more people get screened for the disease.
Kimberly-Clark to hike North American consumer prices
Kimberly-Clark Corp. announced that it plans to raise prices in North America for its baby and child care and consumer tissue businesses. The company said Thursday that the price hikes are slated to take effect during the second and third quarters.
Genacol Canada names scientific director
François-Xavier Lacasse has been appointed scientific director at Genacol Canada Inc. The Quebec-based natural health supplements maker said Tuesday that in the new post, Lacasse will advise the company on scientific matters and on the development of new products.
Nice-Pak expands manufacturing, distribution
Nice-Pak has expanded its wet wipe manufacturing plants and distribution facilities and consolidated and reconfigures its North American operations. The company said Wednesday that it has has introduced new state-of-the-art equipment and packaging technologies in its Jonesboro, Ark.
AstraZeneca supports Crestor with healthy eating partnership
AstraZeneca has partnered with Food University, a culinary education and entertainment platform, to educate people about the importance of maintaining a healthy diet as one way to help manage cholesterol.
Sturman named chairman of CHPA
Pfizer executive Paul Sturman has been elected chairman of the board for the Consumer Healthcare Products Association (CHPA).
Cobalis’ PreHistin honored by ECRM
Cobalis Corp.’s PreHistin Allergy Defense Formula has been recognized with ECRM’s 2011 Best New Product Award.
FDA initiates action against McNeil-PPC
Taking action in the wake of massive product recalls, the Food and Drug Administration has initiated the filing of a consent decree of permanent injunction against McNeil-PPC and two of its officers for failing to comply with federal good manufacturing practice requirements.
P&G global supply chief to retire
Procter & Gamble Co. has announced a leadership succession for its global product supply officer. P&G said Thursday that global product supply officer R. Keith Harrison, 63, is slated to retire on Sept. 1 after more than 41 years of service.
Novartis approved for oral MS medication in Canada
Novartis has been cleared to market the first oral treatment for multiple sclerosis (MS) in Canada. Novartis Pharmaceuticals Canada Inc.